As healthcare professionals, we must combat the alarming vision of a future where everyday infections, such as a scraped knee, become life-threatening due to the growing resistance of germs to traditional treatments. This public healthcare priority is becoming increasingly challenging as bacteria evolve resistance to the essential drugs we use to subdue them. To better understand the gravity of the situation, let’s focus on the insights from Dr. Christina Lin, an infectious diseases expert at Stanford who deals with drug-resistant infections every day.
Year by year, her patients face greater difficulty with their treatment due to the declining effectiveness of previously potent drugs. She often witnesses a scenario where a relatively healthy individual contracts a routine respiratory virus, such as influenza, resulting in their lungs being susceptible to bacterial invasion.
Staphylococcus aureus, commonly known as staph, often thrives under such conditions leading to life-threatening pneumonia. When staph becomes resistant to first-line antibiotics such as penicillins, it escalates into Methicillin-Resistant Staphylococcus Aureus (MRSA), limiting our ability to treat it effectively. If MRSA enters the bloodstream, it could quickly disseminate, resulting in severe illness and long-term complications, pushing doctors to rely on aggressive intravenous antibiotics.
Repercussions of this resistance can be seen in the Centers for Disease Control and Prevention (CDC) 2019 report, which estimates that almost 3 million illnesses, 35,000 deaths in the U.S., and over $20 billion in direct healthcare expenses were due to drug-resistant infections. Such grave consequences mandate a call to action, as the scaled use of antimicrobial drugs in various sectors catalyzes the acceleration of resistance, giving rise to “superbugs” impervious to multiple drugs. Hospitals and clinics, due to their high antimicrobial utilization, contribute significantly to this problem. Hence, there is an urgent need to adopt more judicious antimicrobial stewardship programs.
Equally crucial is the reduction of the spread, which can be achieved via efficient infection prevention programs. Additionally, personal habits like optimal hygiene, safe food preparation, and condom usage, judicious use of antibiotics, and proper disposal of unused medications can significantly contribute to our fight against AMR. Opting for antibiotic-reduced food products and advocating for responsible antimicrobial use in the agriculture industry can also help in controlling AMR.
Moreover, participating politically to shape federal and state policy on antimicrobial stewardship is a powerful mechanism to effect change. Thus, each one of us has a significant part to play in curbing the proliferation of AMR. Preventive measures like vaccinations, robust surveillance systems, proper management programs, and conscious public efforts hold the key to preserving the effectiveness of our drug arsenal. Our active commitment and collective will, we will continue to ensure public health is safeguarded.
Source: https://yourlocalepidemiologistca.substack.com/p/drug-resistant-infections-in-california